3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
10
Gynecologic
4
Dermatologic
4
Thoracic
3
Genitourinary
3
CNS
3
Breast
3
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
413
Leukemia
346
Leukemia, Myeloid, Acute
289
Leukemia, Lymphocytic, Chronic, B-Cell
286
Lymphoma
217
Myelodysplastic Syndromes
207
Lymphoma, Non-Hodgkin
196
Burkitt Lymphoma
160
Lymphoma, Follicular
149
Lymphoma, Mantle-Cell
136
Lymphoma, Large B-Cell, Diffuse
135
Hodgkin Disease
131
Multiple Myeloma
120
Lymphoma, B-Cell, Marginal Zone
118
Lymphoma, Large-Cell, Immunoblastic
95
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
91
Hematologic Neoplasms
87
Myeloproliferative Disorders
85
Leukemia, Myeloid, Chronic-Phase
83
Leukemia, Myeloid, Accelerated Phase
80
Leukemia, Myelomonocytic, Chronic
78
Recurrence
72
Congenital Abnormalities
68
Blast Crisis
64
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
63
Graft vs Host Disease
62
Neoplasms, Plasma Cell
61
Anemia, Refractory, with Excess of Blasts
60
Primary Myelofibrosis
59
Dendritic Cell Sarcoma, Interdigitating
59
Interventions
Psychiatric Rehabilitation
2
Counseling
2
Bupropion
2
pembrolizumab
1
ixabepilone
1
fludarabine
1
Zinc Oxide
1
Varenicline
1
Tobacco Use Cessation Devices
1
Tissue Banks
1
Quality of Life
1
Psychology, Positive
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Observation
1
Nicotine Replacement Therapy
1
Nicotine
1
Molecular Diagnostic Techniques
1
Methods
1
Leucovorin
1
Interleukin-2
1
Interleukin-15
1
Immunotherapy
1
Gene Expression Profiling
1
Gemcitabine
1
Fluorouracil
1
Early Intervention, Educational
1
Drug Therapy
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Cyclophosphamide
×
Other hematologic neoplasm
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled